BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 28189533)

  • 21. Epithelial-Stromal Interactions in Pancreatic Cancer.
    Zhang Y; Crawford HC; Pasca di Magliano M
    Annu Rev Physiol; 2019 Feb; 81():211-233. PubMed ID: 30418798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroma - A Double-Edged Sword in Pancreatic Cancer: A Lesson From Targeting Stroma in Pancreatic Cancer With Hedgehog Signaling Inhibitors.
    Gu J; Saiyin H; Fu D; Li J
    Pancreas; 2018 Apr; 47(4):382-389. PubMed ID: 29521941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal.
    Bijlsma MF; van Laarhoven HW
    Cancer Metastasis Rev; 2015 Mar; 34(1):97-114. PubMed ID: 25566685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stromal biology and therapy in pancreatic cancer: a changing paradigm.
    Neesse A; Algül H; Tuveson DA; Gress TM
    Gut; 2015 Sep; 64(9):1476-84. PubMed ID: 25994217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
    Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
    Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic cancer stroma: controversies and current insights.
    Ansari D; Carvajo M; Bauden M; Andersson R
    Scand J Gastroenterol; 2017; 52(6-7):641-646. PubMed ID: 28276831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward stratification of patients with pancreatic cancer: Past lessons from traditional approaches and future applications with physical biomarkers.
    Koay EJ; Amer AM; Baio FE; Ondari AO; Fleming JB
    Cancer Lett; 2016 Oct; 381(1):237-43. PubMed ID: 26806807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model.
    Choi H; Sheng J; Gao D; Li F; Durrans A; Ryu S; Lee SB; Narula N; Rafii S; Elemento O; Altorki NK; Wong ST; Mittal V
    Cell Rep; 2015 Feb; 10(7):1187-201. PubMed ID: 25704820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.
    Sotgia F; Martinez-Outschoorn UE; Pavlides S; Howell A; Pestell RG; Lisanti MP
    Breast Cancer Res; 2011 Jul; 13(4):213. PubMed ID: 21867571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.
    Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K
    Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor microenvironment participates in metastasis of pancreatic cancer.
    Ren B; Cui M; Yang G; Wang H; Feng M; You L; Zhao Y
    Mol Cancer; 2018 Jul; 17(1):108. PubMed ID: 30060755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stromal biology and therapy in pancreatic cancer.
    Neesse A; Michl P; Frese KK; Feig C; Cook N; Jacobetz MA; Lolkema MP; Buchholz M; Olive KP; Gress TM; Tuveson DA
    Gut; 2011 Jun; 60(6):861-8. PubMed ID: 20966025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-stromal interactions in pancreatic cancer.
    Whatcott C; Han H; Posner RG; Von Hoff DD
    Crit Rev Oncog; 2013; 18(1-2):135-51. PubMed ID: 23237556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in understanding the molecular mechanism of pancreatic cancer metastasis.
    Du YX; Liu ZW; You L; Wu WM; Zhao YP
    Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):361-70. PubMed ID: 27498575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment.
    Yeung TL; Leung CS; Li F; Wong SS; Mok SC
    Biomolecules; 2016 Jan; 6(1):3. PubMed ID: 26751490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroma and pancreatic ductal adenocarcinoma: an interaction loop.
    Luo G; Long J; Zhang B; Liu C; Xu J; Ni Q; Yu X
    Biochim Biophys Acta; 2012 Aug; 1826(1):170-8. PubMed ID: 22521638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deciphering the role of stroma in pancreatic cancer.
    Waghray M; Yalamanchili M; di Magliano MP; Simeone DM
    Curr Opin Gastroenterol; 2013 Sep; 29(5):537-43. PubMed ID: 23892539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting hypoxic tumor microenvironment in pancreatic cancer.
    Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
    J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications.
    Kong X; Li L; Li Z; Xie K
    Cytokine Growth Factor Rev; 2012 Dec; 23(6):343-56. PubMed ID: 22749856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
    Matsuoka T; Yashiro M
    World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.